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Background
The global increase in antibiotic resistance and the high
number of implant-associated infections have rendered
antibiotics ineffective in certain cases. So it’s time for a
new therapy. Bacteriophages are obligatory intracellular
parasites of bacterial cells and bacteria can be infected
by bacteriophages. They have specificity of infection,
due to the presence of specific receptors on the bacter-
ium surface.
Case report
We report the case of a 72 year-old male patient with
recurrent infectious endocarditis with Staphylococcus spp
on an endocavitary stimulation probe and grade III atrio-
ventricular block. The patient had a dual chamber endoca-
vitary cardiac VDD stimulator. The first probe was
inserted through the left supraclavicular region. Because of
a skin infection in this region, the probe was changed to
the right supraclavicular region. During extraction, a frag-
ment of the first probe remained inclavated in the right
atrium.
In February 2012 the patient had the first episode of
fever and chills and he received treatment with vancomy-
cin for 5 weeks with good results. After 8 days, fever and
chills reappeared. The patient was admitted to our hospital
where he started treatment with linezolid and bacterio-
phages. After 1 month the same symptoms reappeared,
and the patient received the same treatment. He remained
afebrile for 2.5 months. The patient had positive hemocul-
tures with different species of Staphylococcus during these
episodes. The following episodes were treated with tigecy-
cline and ceftaroline, but relapse occurred usually after
14-20 days of stopping antibiotic therapy.
Because of the frequent relapses, surgical removal of the
probe remained the only viable option. The patient was
admitted in a cardiovascular clinic, and under antibiotic
protection they tried to remove the probe. Because of
extensive fibrosis around the probe, extraction could not
be performed, and during surgery they noticed a large, fri-
able vegetation, with high risk of rupture. Because of
severe cardiac failure the patient didn’t survive.
Conclusion
The recurrent infection was probably due to biofilm for-
mation on the cardiac probe and infection could not be
medically eradicated, despite the use of antibiotics active
on biofilm. The time span between relapses was longer
when the patient received combined therapy, with phages
and antibiotics. In such difficult to treat cases, it is impor-
tant to set feasible objectives; maintaining quality of life
and lengthening the interval between relapses can be, in
the absence of a surgical cure, the best available option.
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